Tumor cells may also evade immune recognition by the overexpression of immune checkpoints such as cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed cell death protein 1 (PD-1) [76]. Here, CTLA4 is linked to neoplasm.